The Kimberley Prospector

Global News

A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia

RSS
Immune thrombocytopenia (ITP) is a disorder of increased platelet destruction and reduced platelet production and is associated with an increased …

Read more: A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top